Rodwin Marc, Mancini Julien, Duran Ségolène, Jalbert Anne-Céline, Viens Patrice, Maraninchi Dominique, Gonçalves Anthony, Marino Patricia. Corrigendum to “The use of ‘added benefit’ to determine the price of new anti-cancer drugs in France, 2004–2017” [Eur J Canc 145 (2021) 11–18]. European Journal of Cancer. 2021;152:259-261.